Medical News

RSS

Invitae announces dramatic expansion of genetic testing menu

Invitae Corporation (NYSE: NVTA), a genetic information company, has announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will begin releasing the new content between now and the end of the year. Invitae is immediately expanding its menu with dozens of new test panels for hereditary cancer, cardiovascular, neuromuscular, pediatric and other rare disorders.

7 Oct 2015

New white paper on active-ULD performance from CSafe Global

CSafe Global, the world's largest producer of actively controlled mobile refrigeration units for biopharmaceutical and healthcare applications, has released a white paper highlighting the problems and risk associated with using poorly maintained container stock.

7 Oct 2015

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Biogen (NASDAQ: BIIB) will, this week, present data at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Barcelona, Spain, demonstrating the efficacy and safety of TECFIDERA® (dimethyl fumarate) across a broad range of people with relapsing-remitting multiple sclerosis (RRMS).

7 Oct 2015

Primasil innovation helps improve Paxman™ cooling cap

Collaboration between Primasil Silicones and its academic partner University of Huddersfield has enabled Paxman™ to bring relief to cancer patients undergoing chemotherapy by further reducing the risk of hair-loss during treatment.

From Paxman 7 Oct 2015

UL study finds Irish mothers struggle to recognise overweight or obesity in their children

A University of Limerick study has found that mothers of overweight and obese children struggle to recognize their child as overweight or obese. The study reported on 7,655 mothers and their nine year old children using data from the national longitudinal study of children, Growing Up in Ireland.

7 Oct 2015

Cell Therapy Catapult launches Cell History File

The Cell Therapy Catapult, the organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the availability of the Cell History File (CHF) template document. The Cell History File template has been developed in conjunction with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the Human Tissue Authority (HTA) and other cell therapy developers and manufacturers from academia and industry.

7 Oct 2015

Texas Center for Proton Therapy lures top proton talent as Dallas center nears opening

Texas Center for Proton Therapy has announced the hiring of three dedicated radiation oncologists with experience in radiation oncology and proton beam cancer treatment, completing the center’s key medical staff.

7 Oct 2015

Researchers find way to make social media more effective for improving exercise habits in people

Can the Web make people more fit? It's a question hot on the minds of everyone from health insurers to gym owners to public health officials. Although millions of dollars a year are being spent designing promotional ads and social media campaigns, they clearly aren't working: more than 43 percent of Americans get insufficient levels of daily exercise, and nearly a third are obese.

7 Oct 2015

MPFI scientist receives NIH's Pioneer Award

Max Planck Florida Institute for Neuroscience Scientific Director, Ryohei Yasuda, has received the National Institute of Health's Pioneer Award, which recognizes scientists who have demonstrated creativity and groundbreaking approaches in biomedical or behavioral science.

7 Oct 2015

MIT researchers developing computer system to help predict effects of disease on brain anatomy

MIT researchers are developing a computer system that uses genetic, demographic, and clinical data to help predict the effects of disease on brain anatomy.

7 Oct 2015

Three researchers recognised for their contributions to Australian medical research

Three top Walter and Eliza Hall Institute researchers have been recognised for their contributions to Australian medical research, with their election as fellows of the Australian Academy of Health and Medical Sciences.

7 Oct 2015

2-year advanced melanoma survival benefit with dabrafenib, trametinib combination

Updated results from the COMBI-v trial show significantly improved overall and progression-free survival with first-line dabrafenib plus trametinib compared with vemurafenib in patients with advanced melanoma.

7 Oct 2015

Everolimus, 177Lu-dotatate extend neuroendocrine tumour PFS

Positive progression-free survival results from the RADIANT-4 and NETTER-1 trials extend the armamentarium for physicians treating patients with neuroendocrine tumours.

7 Oct 2015

Brain metastases evolve ‘clinically actionable’ mutations

Brain metastatic disease shows branched evolution from the primary tumour, suggest preliminary findings from the largest massively parallel sequencing study of paired samples performed so far.

7 Oct 2015

Elsevier announces winners of first triennial IEA Elsevier John Wilson Award

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the winners of the first triennial IEA Elsevier John Wilson Award.

7 Oct 2015

Adeptus Health closes $175 million of new senior secured credit facilities

Adeptus Health Inc., the largest operator of freestanding emergency rooms in the U.S., today announced that it has closed on $175 million of new senior secured credit facilities. Bank of America Merrill Lynch served as administrative agent. Bank of Montreal and SunTrust Bank served as co-syndication agents.

7 Oct 2015

VWR announces acquisition of Purification Technologies

VWR, a leading, global, independent provider of laboratory products, services and solutions, announced today that it has acquired Purification Technologies Inc., a specialty solvent company that performs high volume purification of selected high purity solvents. This acquisition will enhance VWR's growing laboratory and production chemical manufacturing portfolio to better support its laboratory and biopharmaceutical manufacturing customers.

7 Oct 2015

IQWiG finds no added benefit for ceritinib drug in adults with NSCLC

The drug ceritinib (trade name: Zykadia) has been approved since May 2015 for the treatment of adults with non-small cell lung cancer (NSCLC). It is an option when certain changes in the cancer cells (anaplastic lymphoma kinase-positive) stimulate tumour growth and patients have already been pretreated with crizotinib.

7 Oct 2015

Houston Methodist-led research team one step closer to developing technologies to fix broken bones

A collaborative research team led by scientists at Houston Methodist is one step closer to developing technologies that could help mend broken bones faster. The Department of Defense awarded close to $6 million to the Houston Methodist Research Institute for an initiative aimed at studying two new materials to repair complex fractures in long bones.

7 Oct 2015

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Immune Pharmaceuticals, Inc. announced today that it has submitted an Investigational New Drug Application in the U.S. to expand recruiting for its first in class lead product candidate, Bertilimumab, for the treatment of Bullous Pemphigoid (BP).

7 Oct 2015

Medical News

Invitae announces dramatic expansion of genetic testing menu

New white paper on active-ULD performance from CSafe Global

Interim data from long-term extension Tecfidera® (dimethyl fumarate) study

Primasil innovation helps improve Paxman™ cooling cap

UL study finds Irish mothers struggle to recognise overweight or obesity in their children

Cell Therapy Catapult launches Cell History File

Texas Center for Proton Therapy lures top proton talent as Dallas center nears opening

Researchers find way to make social media more effective for improving exercise habits in people

MPFI scientist receives NIH's Pioneer Award

MIT researchers developing computer system to help predict effects of disease on brain anatomy

Three researchers recognised for their contributions to Australian medical research

2-year advanced melanoma survival benefit with dabrafenib, trametinib combination

Everolimus, 177Lu-dotatate extend neuroendocrine tumour PFS

Brain metastases evolve ‘clinically actionable’ mutations

Elsevier announces winners of first triennial IEA Elsevier John Wilson Award

Adeptus Health closes $175 million of new senior secured credit facilities

VWR announces acquisition of Purification Technologies

IQWiG finds no added benefit for ceritinib drug in adults with NSCLC

Houston Methodist-led research team one step closer to developing technologies to fix broken bones

Immune submits Bertilimumab IND application to FDA for treatment of Bullous Pemphigoid

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News